KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Return on Invested Capital (2019 - 2025)

Historic Return on Invested Capital for Xenon Pharmaceuticals (XENE) over the last 7 years, with Q3 2025 value amounting to 0.58%.

  • Xenon Pharmaceuticals' Return on Invested Capital fell 2700.0% to 0.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.58%, marking a year-over-year decrease of 2700.0%. This contributed to the annual value of 0.34% for FY2024, which is 800.0% down from last year.
  • As of Q3 2025, Xenon Pharmaceuticals' Return on Invested Capital stood at 0.58%, which was down 2700.0% from 0.48% recorded in Q2 2025.
  • In the past 5 years, Xenon Pharmaceuticals' Return on Invested Capital ranged from a high of 0.13% in Q2 2022 and a low of 0.58% during Q3 2025
  • In the last 5 years, Xenon Pharmaceuticals' Return on Invested Capital had a median value of 0.26% in 2021 and averaged 0.28%.
  • Per our database at Business Quant, Xenon Pharmaceuticals' Return on Invested Capital surged by 1200bps in 2022 and then tumbled by -2700bps in 2025.
  • Over the past 5 years, Xenon Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.2% in 2021, then increased by 11bps to 0.18% in 2022, then plummeted by -56bps to 0.27% in 2023, then plummeted by -34bps to 0.37% in 2024, then plummeted by -58bps to 0.58% in 2025.
  • Its Return on Invested Capital stands at 0.58% for Q3 2025, versus 0.48% for Q2 2025 and 0.41% for Q1 2025.